UK markets close in 3 hours 16 minutes
  • FTSE 100

    7,021.19
    +3.72 (+0.05%)
     
  • FTSE 250

    22,250.87
    -73.32 (-0.33%)
     
  • AIM

    1,220.48
    -9.32 (-0.76%)
     
  • GBP/EUR

    1.1672
    +0.0036 (+0.31%)
     
  • GBP/USD

    1.3877
    +0.0068 (+0.49%)
     
  • BTC-GBP

    23,429.04
    -977.83 (-4.01%)
     
  • CMC Crypto 200

    796.72
    -143.22 (-15.24%)
     
  • S&P 500

    4,166.45
    -55.41 (-1.31%)
     
  • DOW

    33,290.08
    -533.32 (-1.58%)
     
  • CRUDE OIL

    71.72
    +0.08 (+0.11%)
     
  • GOLD FUTURES

    1,782.30
    +13.30 (+0.75%)
     
  • NIKKEI 225

    28,010.93
    -953.15 (-3.29%)
     
  • HANG SENG

    28,489.00
    -312.27 (-1.08%)
     
  • DAX

    15,549.19
    +101.15 (+0.65%)
     
  • CAC 40

    6,583.11
    +13.95 (+0.21%)
     

Global Injectable Drugs Market (2021 Edition) – Analysis By Molecule (Small, Large), Delivery (Prefilled, Infusion, Others), Product, By Region, By Country: Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)

·3-min read

Executive Summary The Global Injectable Drugs Market was valued at USD 414. 88 Billion in the year 2020. Increasing prevalence of diseases such as diabetes, cancer and auto-immune disorders like rheumatoid arthritis and multiple sclerosis with an upsurge in the number of chronic diseases have driven the need for drug delivery systems and a higher demand for Injectable drugs.

New York, June 01, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Injectable Drugs Market (2021 Edition) – Analysis By Molecule (Small, Large), Delivery (Prefilled, Infusion, Others), Product, By Region, By Country: Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)" - https://www.reportlinker.com/p06079763/?utm_source=GNW
Increasing use of self-administered Injectable formulations like auto injectors, pen injectors, pre-filled syringes (PFS) and needle-free injectors has led to greater acceptance of Injectables.

The injectable drugs market is characterised by regulatory challenges, the pricing pressures, patent expiries and drug shortages. Major demand in complex segments such as large molecule peptides and vaccines couple with the shortage of injectables in the United States holds major opportunities for the injectables market. The large molecule injectable drugs market is projected to grow at a rapid pace in the next few years. Increase in the geriatric population and rise in prevalence of chronic diseases such as diabetes and cancer are the key factors driving the market.

North America dominates the Injectable Drugs market, owing to rapid developments in healthcare infrastructure, the presence of major players in the region, huge investments made in the research and development, and increased adoption of oncology-related drugs in hospitals to treat different cancers.

Asia Pacific region is expected to register the fastest growth in global injectable market during the forecast period. Additionally, there is an increase in the number of new drug formulations which are less water soluble and/or have very low permeability to allow for adequate absorption from the gastrointestinal tract following oral administration. The only way to make such drugs available in the body is through an intravenous administration.

Scope of the Report
• The report presents the analysis of Injectable Drugs market for the historical period of 2016-2020 and the forecast period of 2021-2026.

• The report analyses the Injectable Drugs Market by value (USD Billion).

• The report analyses the Injectable Drugs Market by Product (Complex Biologics, Conventional Therapeutic, Vaccines, Insulin).

• The report analyses the Injectable Drugs Market by Molecule (Small Molecule, Large Molecule).

• The report analyses the Injectable Drugs Market by Delivery (Prefilled Syringe, Infusions, Others).

• The Global Injectable Drugs Market has been analysed By Region (North America Europe, Asia Pacific, MEA) By Country (United States, Canada, Germany, U.K, France, Italy, China, Japan, India, South Korea).

• The key insights of the report have been presented through the frameworks of the attractiveness of the market has been presented by region, by product, By Molecule, By Delivery

• Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.

• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Johnson & Johnson, Pfizer, GlaxoSmithKline, Novartis, Eli Lilly and Company, AstraZeneca Plc, Sanofi, Merck KGaA, Novo Nordisk, Baxter International.

Key Target Audience

• Healthcare and Pharmaceutical Companies

• Consulting and Advisory Firms

• Government and Policy Makers

• Regulatory Authorities
Read the full report: https://www.reportlinker.com/p06079763/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting